ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

ACS Modifies Pap Test Guidelines

November 27, 1987

Beyond Planned Parenthood: Attendance Flags at Komen Flagship Race, D.C. Participation Drops by Nearly One-Third

June 8, 2012

ACS Research Grants Hit $78.2 Million

July 18, 1986

Natcher Subcommittee Objects To Budget Reductions, Squeeze From DeVita Details On Programs Being Cut

March 15, 1985

Building Boom of Proton Beam Centers Flares Up in Washington and Baltimore

October 25, 2013